According to IMARC Group’s latest report, titled “Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global travel vaccines market size reached a value of US$ 3.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2027, exhibiting at a CAGR of 11.1% during 2022-2027.
Year Considered to Estimate the Market Size:
Base Year of the Analysis: 2021
Historical Period: 2016-2021
Forecast Period: 2022-2027
Global Travel Vaccines Market Overview:
Travel vaccines, or travel immunizations, are biologically formulated injections that are administered in an individual’s body before traveling to protect them against potentially deadly infections and diseases. These medications stimulate the immune system by creating antibodies that assist in fragmenting and defending consumers from microorganisms and pathogens. Apart from this, travel vaccinations are reliable and cost-efficient, and they prevent the occurrence of life-threatening diseases and minimize microbial invasion amongst visitors’ bodies. Consequently, mono and combination immunization travel vaccinations are strongly prescribed by healthcare professionals to an individual visiting developed or endemic countries. Currently, recommendations vary from person to person based on the tourist’s gender, age, and medical history.
Download free sample brochure: https://www.imarcgroup.com/travel-vaccines-market/requestsample
Global Travel Vaccines Market Trends:
The global travel vaccines market is primarily driven by the rapid expansion in the tourism industry and the growing number of international tourist arrivals, especially during the various endemic ailments, such as COVID-19. In line with this, the increasing prevalence of multiple infectious and travel-related viruses, including hepatitis, tetanus, Japanese encephalitis, meningitis, and yellow fever, has supplemented the demand for travel vaccines. Additionally, the numerous initiatives being undertaken by regulatory authorities for mandating travel vaccination policies for tourists prior to visiting in certain disease-prone regions are favoring the market growth. Moreover, the introduction of messenger ribonucleic acid (mRNA) vaccines that correspond to the genetic sequence and help the body make necessary infection-fighting proteins is propelling the market growth. Besides this, ongoing funding in research and development (R&D) projects for creating effective vaccinations is supporting the market growth.
Checkout Now: https://www.imarcgroup.com/checkout?id=1155&method=1
Travel Vaccines Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the travel vaccines market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- GlaxoSmithKline Pharmaceuticals Limited
- Sanofi Pasteur
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- ALK-Abelló A/S
- Bavarian Nordic A/S
- Crucell (Subsidiary of Johnson & Johnson)
- CSL Limited
- AstraZeneca PLC
- Altimmune, Inc.
- Abbott Laboratories
- Hoffmann-La Roche, Inc.
Key Market Segmentation:
The report has segmented the global travel vaccines market on the basis of composition, disease and region.
Breakup by Composition:
- Mono Vaccines
- Combination Vaccines
Breakup by Disease:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Breakup by Region:
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
- Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=1155&flag=C
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
